ULK1 and neoplasm: The novelty of our study resides in the demonstration that the PI3K/mTOR inhibitor NVP-BEZ235 induces autophagy by AMPK/ULK1 pathway and the combinational treatment of NVP-BEZ235 and CQ further promote apoptosis to suppress tumor growth (Fig. 6).